Segmental copy-number gain within the region of isopentenyl diphosphate isomerase genes in sporadic amyotrophic lateral sclerosis

Biochemical and Biophysical Research Communications

Volumn 402, Issue 2, 2010, Pages 438-442

  Kato, Takeo ^a   Emi, Mitsuru ^a,b   Sato, Hidenori ^a,b   Arawaka, Shigeki ^a   Wada, Manabu ^a   Kawanami, Toru ^a   Katagiri, Tadashi ^c   Tsuburaya, Kenji ^d   Toyoshima, Itaru ^e   Tanaka, Fumiaki ^f   Sobue, Gen ^f   Matsubara, Kenichi ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b DNA CHIP RESEARCH INC   (Japan)

^c Yamagata Prefectural Kahoku Hospital   (Japan)

^d Yamagata National Hospital   (Japan)

^e AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Copy number variation; Isopentenyl diphosphate isomerase; Polymorphism; Segmental gain; Subtelomere

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHROMOSOME 10P; CHROMOSOME 2Q; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE; GENETIC RISK; GENETIC SCREENING; HUMAN; ISOPENTENYL DIPHOSPHATE ISOMERASE 1 GENE; ISOPENTENYL DIPHOSPHATE ISOMERASE 2 GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPORADIC AMYOTROPHIC LATERAL SCLEROSIS;

AMYOTROPHIC LATERAL SCLEROSIS; CARBON-CARBON DOUBLE BOND ISOMERASES; CHROMOSOMES, HUMAN, PAIR 10; GENE DOSAGE; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TELOMERE;

EID: 78149464874     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.056     Document Type: Article

References (36)

1. Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010, 19:R46-R64.
2. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuur S., Kobatake K., Morimoto N., Abe K., Suzuki N., Aoki M., Kawata A., Hirai T., Kato T., Ogasawara K., Hirano A., Takumi T., Kusaka H., Hagiwara K., Kaji R., Kawakami H. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465:223-226.
3. Graham A.J., Macdonald A.M., Hawkes C.H. British motor neuron disease twin study. J. Neurol. Neurosurg. Psychiatry 1997, 62:562-569.
4. van Es M.A., van Vught P.W., Blauw H.M., Franke L., Saris C.G., Andersen P.M., Van Den Bosch L., de Jong S.W., van't Slot R., Birve A., Lemmens R., de Jong V., Baas F., Schelhaas H.J., Sleegers K., Van Broeckhoven C., Wokke J.H., Wijmenga C., Robberecht W., Veldink J.H., Ophoff R.A., van den Berg L.H. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol. 2007, 6:869-877.
5. Dunckley T., Huentelman M.J., Craig D.W., Pearson J.V., Szelinger S., Joshipura K., Halperin R.F., Stamper C., Jensen K.R., Letizia D., Hesterlee S.E., Pestronk A., Levine T., Bertorini T., Graves M.C., Mozaffar T., Jackson C.E., Bosch P., McVe A., Dick A., Barohn R., Lomen-Hoerth C., Rosenfeld J., O'connor D.T., Zhang K., Crook R., Ryberg H., Hutton M., Katz J., Simpson E.P., Mitsumoto H., Bowser R., Miller R.G., Appel S.H., Stephan D.A. Whole-genome analysis of sporadic amyo trophic lateral sclerosis. N. Engl. J. Med. 2007, 357:775-788.
6. van Es M.A., van Vught P.W., Blauw H.M., Franke L., Saris C.G., Van den Bosch L., de Jong S.W., de Jong V., Baas F., van't Slot R., Lemmens R., Schelhaas H.J., Birve A., Sleegers K., Van Broeckhoven C., Schymick J.C., Traynor B.J., Wokke J.H., Wijmenga C., Robberecht W., Andersen P.M., Veldink J.H., Ophoff R.A., van den Berg L.H. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 2008, 40:29-31.
7. Cronin S., Berger S., Ding J., Schymick J.C., Washecka N., Hernandez D.G., Greenway M.J., Bradley D.G., Traynor B.J., Hardiman O. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum. Mol. Genet. 2008, 17:768-774.
8. van Es M.A., Veldink J.H., Saris C.G., Blauw H.M., van Vught P.W., Birve A., Lemmens R., Schelhaas H.J., Groen E.J., Huisman M.H., van der Kooi A.J., de Visser M., Dahlberg C., Estrada K., Rivadeneira F., Hofman A., Zwarts M.J., van Doormaal P.T., Rujescu D., Strengman E., Giegling I., Muglia P., Tomik B., Slowik A., Uitterlinden A.G., Hendrich C., Waibel S., Meyer T., Ludolph A.C., Glass J.D., Purcell S., Cichon S., Nöthen M.M., Wichmann H.E., Schreiber S., Vermeulen S.H., Kiemeney L.A., Wokke J.H., Cronin S., McLaughlin R.L., Hardiman O., Fumoto K., Pasterkamp R.J., Meininger V., Melki J., Leigh P.N., Shaw C.E., Landers J.E., Al-Chalabi A., Brown R.H., Robberecht W., Andersen P.M., Ophoff R.A., van den Berg L.H. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet. 2009, 41:1083-1087.
9. Schymick J.C., Scholz S.W., Fung H.C., Britton A., Arepalli S., Gibbs J.R., Lombardo F., Matarin M., Kasperaviciute D., Hernandez D.G., Crews C., Bruijn L., Rothstein J., Mora G., Restagno G., Chiò A., Singleton A., Hardy J., Traynor B.J. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 2007, 6:322-328.
10. Cronin S., Tomik B., Bradley D.G., Slowik A., Hardiman O. Screening for replication of genome-wide SNP associations in sporadic ALS. Eur. J. Hum. Genet. 2009, 17:213-218.
11. Chiò A., Schymick J.C., Restagno G., Scholz S.W., Lombardo F., Lai S.L., Mora G., Fung H.C., Britton A., Arepalli S., Gibbs J.R., Nalls M., Berger S., Kwee L.C., Oddone E.Z., Ding J., Crews C., Rafferty I., Washecka N., Hernandez D., Ferrucci L., Bandinelli S., Guralnik J., Macciardi F., Torri F., Lupoli S., Chanock S.J., Thomas G., Hunter D.J., Gieger C., Wichmann H.E., Calvo A., Mutani R., Battistini S., Giannini F., Caponnetto C., Mancardi G.L., La Bella V., Valentino F., Monsurrò M.R., Tedeschi G., Marinou K., Sabatelli M., Conte A., Mandrioli J., Sola P., Salvi F., Bartolomei I., Siciliano G., Carlesi C., Orrell R.W., Talbot K., Simmons Z., Connor J., Pioro E.P., Dunkley T., Stephan D.A., Kasperaviciute D., Fisher E.M., Jabonka S., Sendtner M., Beck M., Bruijn L., Rothstein J., Schmidt S., Singleton A., Hardy J., Traynor B.J. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 2009, 18:1524-1532.
12. R. Fernández-Santiago, M. Sharma, D. Berg, T. Illig, J. Anneser, T. Meyer, A. Ludolph, T. Gasser, No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort, Neurobiol. Aging (2009), May 21 (Epub ahead of print).
13. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., Cho E.K., Dallaire S., Freeman J.L., González J.R., Gratacòs M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F., Zhang J., Zerjal T., Zhang J., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., Hurles M.E. Global variation in copy number in the human genome. Nature 2006, 444:444-454.
14. Lupski J.R. Genomic rearrangements and sporadic disease. Nat. Genet. 2007, 39:S43-S47.
15. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 1994, 124(Suppl.):96-107.
16. Nagasawa H., Wada M., Arawaka S., Kawanami T., Kurita K., Daimon M., Adachi M., Hosoya T., Emi M., Muramatsu M., Kato T. A polymorphism of the aldehyde dehydrogenase 2 gene is a risk factor for multiple lacunar infarcts in Japanese men: the Takahata Study. Eur. J. Neurol. 2007, 14:428-434.
17. Iseki C., Kawanami T., Nagasawa H., Wada M., Koyama S., Kikuchi K., Arawaka S., Kurita K., Daimon M., Mori E., Kato T. Asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on MRI (AVIM) in the elderly: a prospective study in a Japanese population. J. Neurol. Sci. 2009, 277:54-57.
18. Stefansson H., Rujescu D., Cichon S., Pietiläinen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., Hansen T., Jakobsen K.D., Muglia P., Francks C., Matthews P.M., Gylfason A., Halldorsson B.V., Gudbjartsson D., Thorgeirsson T.E., Sigurdsson A., Jonasdottir A., Jonasdottir A., Bjornsson A., Mattiasdottir S., Blondal T., Haraldsson M., Magnusdottir B.B., Giegling I., Möller H.J., Hartmann A., Shianna K.V., Ge D., Need A.C., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Paunio T., Toulopoulou T., Bramon E., Di Forti M., Murray R., Ruggeri M., Vassos E., Tosato S., Walshe M., Li T., Vasilescu C., Mühleisen T.W., Wang A.G., Ullum H., Djurovic S., Melle I., Olesen J., Kiemeney L.A., Franke B., Sabatti C., Freimer N.B., Gulcher J.R., Thorsteinsdottir U., Kong A., Andreassen O.A., Ophoff R.A., Georgi A., Rietschel M., Werge T., Petursson H., Goldstein D.B., Nöthen M.M., Peltonen L., Collier D.A., St Clair D., Stefansson K. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
20. de Smith A.J., Tsalenko A., Sampas N., Scheffer A., Yamada N.A., Tsang P., Ben-Dor A., Yakhini Z., Ellis R.J., Bruhn L., Laderman S., Froguel P., Blakemore A.I. Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases. Hum. Mol. Genet. 2007, 16:2783-2794.
21. Sharp A.J., Hansen S., Selzer R.R., Cheng Z., Regan R., Hurst J.A., Stewart H., Price S.M., Blair E., Hennekam R.C., Fitzpatrick C.A., Segraves R., Richmond T.A., Guiver C., Albertson D.G., Pinkel D., Eis P.S., Schwartz S., Knight S.J., Eichler E.E. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat. Genet. 2006, 38:1038-1042.
22. Lupski J.R. Genomic disorders ten years on. Genome Med. 2009, 1:42.
23. Blauw H.M., Veldink J.H., van Es M.A., van Vught P.W., Saris C.G., van der Zwaag B., Franke L., Burbach J.P., Wokke J.H., Ophoff R.A., van den Berg L.H. Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen. Lancet Neurol. 2008, 7:319-326.
24. Cronin S., Blauw H.M., Veldink J.H., van Es M.A., Ophoff R.A., Bradley D.G., van den Berg L.H., Hardiman O. Analysis of genome-wide copy number variation in Irish and Dutch ALS populations. Hum. Mol. Genet. 2008, 17:3392-3398.
25. Wain L.V., Pedroso I., Landers J.E., Breen G., Shaw C.E., Leigh P.N., Brown R.H., Tobin M.D., Al-Chalabi A. The role of copy number variation in susceptibility to amyotrophic lateral sclerosis: genome-wide association study and comparison with published loci. PLoS ONE 2009, 4:e8175.
26. Cooper G.M., Zerr T., Kidd J.M., Eichler E.E., Nickerson D.A. Systematic assessment of copy number variant detection via genome-wide SNP genotyping. Nat. Genet. 2008, 40:1199-1203.
27. Itsara A., Cooper G.M., Baker C., Girirajan S., Li J., Absher D., Krauss R.M., Myers R.M., Ridker P.M., Chasman D.I., Mefford H., Ying P., Nickerson D.A., Eichler E.E. Population analysis of large copy number variants and hotspots of human genetic disease. Am. J. Hum. Genet. 2009, 84:148-161.
28. Sharp A.J., Locke D.P., McGrath S.D., Cheng Z., Bailey J.A., Vallente R.U., Pertz L.M., Clark R.A., Schwartz S., Segraves R., Oseroff V.V., Albertson D.G., Pinkel D., Eichler E.E. Segmental duplications and copy-number variation in the human genome. Am. J. Hum. Genet. 2005, 77:78-88.
29. Ramos-Valdivia A.C., van der Heijden R., Verpoorte R. Isopentenyl diphosphate isomerase: a core enzyme in isoprenoid biosynthesis. A review of its biochemistry and function. Nat. Prod. Rep. 1997, 14:591-603.
30. Yochem J., Hall D.H., Bell L.R., Hedgecock E.M., Herman R.K. Isopentenyl-diphosphate isomerase is essential for viability of Caenorhabditis elegans. Mol. Genet. Genomics 2005, 273:158-166.
31. Niebroj-Dobosz I., Rafałowska J., Fidziańska A., Gadamski R., Grieb P. Myelin composition of spinal cord in a model of amyotrophic lateral sclerosis (ALS) in SOD1G93A transgenic rats. Folia Neuropathol. 2007, 45:236-241.
32. Anderson S., Gustafsson N., Warner M., Gustafsson J.A. Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice. Proc. Natl. Acad. Sci. USA 2005, 102:3857-3862.
33. Zhai J., Ström A.-L., Kilty R., Venkatakrishnan P., White J., Everson W.V., Smart E.J., Zhu H. Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord. FEBS J. 2009, 276:3308-3323.
34. Dupuis L., Corcia P., Fergani A., Gonzalez De Aguilar J.-L., Bonnefont-Rousselot D., Bittar R. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008, 70:1004-1009.
35. Golomb B.A., Kwon E.K., Koperski S., Evans M.A. Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study. Drug Saf. 2009, 32:649-661.
36. Zinman L., Sadeghi R., Gawel M., Patton D., Kiss A. Are statin medications safe in patients with ALS?. Amyotroph. Lateral Scler. 2008, 9:223-228.